Marc Claussen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

This cost-consequence analysis suggests selective early rescue surfactant administration strategies are associated with a lower healthcare burden in premature infants with RDS.

United statesNorth carolinaUnited kingdomChiesi farmaceuticiMarc claussenB corpChiesi groupChiesi united states incHealth economicCertifiedb corporationPediatric pharmacologyVice presidentMarket accessChiesi unitedValue informationIntratracheal suspension